Last edition
News about Drug Discovery & Development
With this new capability, Syngene will offer fully integrated, end-to-end services for antibody-drug conjugates (ADCs) – from discovery through to GMP manufacturing – placing it among a handful of CDMOs with full-service capabilities.
Drug Discovery & Development | 24/10/2025 | By Darshana | 212
Danish drugmaker Novo Nordisk has entered into a definitive asset purchase and license agreement with US-based Omeros Corporation for zaltenibart (formerly OMS906), a clinical-stage antibody therapy being developed for rare blood and kidney disorders.
Drug Discovery & Development | 16/10/2025 | By Dineshwori | 273
EG BioMed Earns CAP Accreditation, Boosting YD Bio's Cancer Diagnostics
EG BioMed is one of YD Bio’s key licensing partners for pancreatic and breast cancer detection and collaborates with 3D Global to develop treatments for eye disorders.
Drug Discovery & Development | 13/10/2025 | By Darshana | 214
India’s small and mid-sized pharmaceutical manufacturers are raising alarms over new good manufacturing practice (GMP) and bio-equivalence mandates, warning that the regulations could widen the gap between large companies and micro, small, and medium enterprises (MSMEs).
Drug Discovery & Development | 13/10/2025 | By Darshana | 613
Zenas BioPharma Signs USD 2 Billion Licensing Deal with InnoCare for Autoimmune Drugs
Zenas BioPharma has entered into a licensing agreement with China’s InnoCare Pharma worth up to USD 2 billion to develop and commercialise three autoimmune drug candidates, including a late-stage treatment for multiple sclerosis.
Drug Discovery & Development | 09/10/2025 | By Darshana | 327
Through the partnership among Sai Life Sciences, Agility Life Sciences and Centrix Pharma Solutions, customers will have access to integrated drug substance and drug product development, helping them move efficiently from pre-clinical studies to First-In-Human (FIH) clinical trials and beyond.
Drug Discovery & Development | 09/10/2025 | By Dineshwori | 162
BD and Opentrons Collaborate to Automate Single-Cell Multiomics Workflows
BD (Becton, Dickinson and Company) and Opentrons Labworks, Inc. have entered into a multi-year collaboration to accelerate advances in single-cell multiomics research by integrating robotic automation into critical laboratory workflows.
Drug Discovery & Development | 08/10/2025 | By Darshana | 364
Omalizumab, the active ingredient in Xolair, is a prescription biologic used to improve the control of severe persistent allergic asthma in patients aged six years and older when blood tests confirm immunoglobulin E (IgE) involvement.
Drug Discovery & Development | 07/10/2025 | By Darshana | 280
Illumina Launches BioInsight to Drive Multiomic Data and AI-Powered Drug Discovery
Illumina, Inc., a global leader in genomics and precision health, has announced the launch of BioInsight, a new business designed to meet the growing demand for deeper biological insights driven by large-scale multiomic data.
Drug Discovery & Development | 04/10/2025 | By Darshana | 803
Bristol Myers and Takeda Join AI Consortium to Accelerate Drug Discovery
Bristol Myers Squibb and Takeda Pharmaceuticals have agreed to collaborate in a new AI-driven drug discovery initiative, pooling proprietary molecular structure datasets to train an advanced AI model known as OpenFold3.
Drug Discovery & Development | 01/10/2025 | By Darshana | 743
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy